Skip to content
Screener

Reported August 11, 2026 · Before market open

EPS-$1.11Miss by $0.24
EPS estimate-$0.87

Next report

Nov 5, 2026 (in 2 months)
EPS estimate-$0.94

FAQ

When did Intensity Therapeutics, Inc. report Q2 2026 earnings?
Intensity Therapeutics, Inc. (INTS) reported Q2 2026 earnings on August 11, 2026 before market open.
What were Intensity Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Intensity Therapeutics, Inc. reported eps of $-1.11 for Q2 2026.
Did Intensity Therapeutics, Inc. beat estimates in Q2 2026?
EPS missed the consensus estimate of $-0.87 by $0.24.
How did Intensity Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 753.8% from $-0.13.
Where can I find Intensity Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001567264-26-000061) and the 10-Q periodic report (0001567264-26-000059) directly on SEC EDGAR. The filing index links above go to sec.gov.